⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Alzheimer's Therapeutics Market to Reach USD 10.4 Billion by 2036 as Disease-Modifying Immunotherapies Transform Treatment Paradigms
accessnewswire.com
ABBV
BMY
JNJ
LLY
NVS
REGN
BIIB
ACROBiosystems fördert Innovationen bei JPM Spotlight-Sessions von bioSeedin und unterstützt strategisch den Aufbau globaler Partnerschaften USA - Deutsch USA - English USA - español USA - Français
prnewswire.com
PFE
ABBV
TSE
GSK
ACROBiosystems stimule l'innovation au cours du JPM Spotlight de bioSeedin, en soutenant stratégiquement l'établissement de partenariats mondiaux USA - Français USA - English USA - español USA - Deutsch
prnewswire.com
PFE
LLY
ABBV
GSK
BMY
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
AVBP
SMMT
MRUS
MRK
GNPX
CGEM
ABBV
BMY
BDTX
LTRN
PFE
JNJ
LLY
ACROBiosystems impulsa la innovación en JPM Spotlight de bioSeedin USA - español USA - English
prnewswire.com
PFE
ABBV
TSEM
GSK
Dermal Fillers Market Forecast 2026-2036: Global Revenue to Reach USD 9.9 Billion by 2036 at 3.2%
prnewswire.com
ABBV
SUNE
Crystalys Therapeutics Appoints Tim Walbert, Former Horizon Therapeutics CEO, as Independent Board Director
prnewswire.com
AMGN
ABBV
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging
prnewswire.com
PFE
ABBV
GSK
BMY
Octane's Neuro Tech Forum 2026 March 26-27
prnewswire.com
JNJ
ABBV
PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExplore™ for Standardized Histopathology Endpoints
globenewswire.com
ABBV